pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 545 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 3
catequentinib hydrochloride
Soft Tissue Sarcoma
Advenchen Laboratories LLC
0 catalysts
Phase 3
cebranopadol
Pain
Nociceptin receptorOpioid receptors; mu/kappa/delta
Tris Pharma Inc
0 catalysts
Phase 3
cediranib maleate
Epithelial Ovarian Cancer
$AZNASTRAZENECA PLC
catalysts
← prev
page 8 of 19
next →
131
Pain89
Neurology1
0
Phase 3
celiprolol
EDSIVO (celiprolol [INN])
Ehlers-Danlos Syndrome Vascular Type (Type IV)
$ZVRAZEVRA THERAPEUTICS, INC.
0 catalysts
Phase 3
cemdisiran + pozelimab
Myasthenia Gravis
$REGNREGENERON PHARMACEUTICALS, INC.
0 catalysts
Phase 3
cenerimod
Systemic Lupus Erythematosus
Sphingosine 1-phosphate receptor 1
Idorsia Pharmaceutical Ltd
0 catalysts
Phase 3
cetoquagene parvec
Xerostomia
$MGTXMeiraGTx Holdings plc
0 catalysts
Phase 3
cetuximab sarotalocan
Recurrent Head And Neck Squamous Cell Carcinoma
Epidermal growth factor receptor
Rakuten Medical Inc
0 catalysts
Phase 3
choline chloride
Intrachol (choline chloride [INN])
Liver Diseases
$TARAProtara Therapeutics, Inc.
0 catalysts
Phase 3
cintredekin besudotox
Glioblastoma Multiforme (GBM)
Interleukin 13 receptorInterleukin-13 receptor subunit alpha-2
Precision Neuromed Inc
0 catalysts
Phase 3
civorebrutinib
civorebrutinib [INN]
Neuromyelitis Optica (Devic's Syndrome)
SinoMab Bioscience Ltd
0 catalysts
Phase 3
clazakizumab
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)
Interleukin-6
$CSLLYCSL LTD
0 catalysts
Phase 3
clemizole hydrochloride
Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy)
$HRMYHarmony Biosciences Holdings, Inc.
0 catalysts
Phase 3
cliramitug
Amyloid Cardiomyopathy
Alexion Pharmaceuticals Inc
0 catalysts
Phase 3
coagulation factor X (human)
Coagadex (coagulation factor X (human))
Stuart Prower Factor Deficiency (Factor X Deficiency)
Kedrion SpA
0 catalysts
Phase 3
contezolid
Diabetic Foot Infection (DFI)
Bacterial 70S ribosome
MicuRx Pharmaceuticals Inc
0 catalysts
Phase 3
contezolid acefosamil
Diabetic Foot Infection (DFI)
Bacterial 70S ribosome
MicuRx Pharmaceuticals Inc
0 catalysts
Phase 3
coramitug
Amyloid Cardiomyopathy
Novo Nordisk AS
0 catalysts
Phase 3
crenolanib besylate
Refractory Acute Myeloid Leukemia
Arog Pharmaceuticals Inc
0 catalysts
Phase 3
cretostimogene grenadenorepvec
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
$CGONCG Oncology, Inc.
0 catalysts
Phase 3
crovalimab
Piasky (crovalimab-akkz)
Atypical Hemolytic Uremic Syndrome (Nondiarrhea - Associated Hemolytic Uremic…
Complement C5
F. Hoffmann-La Roche Ltd
0 catalysts
Phase 3
dabocemagene autoficel
Dystrophic Epidermolysis Bullosa
Castle Creek Biosciences Inc
0 catalysts
Phase 3
dalcetrapib
Acute Coronary Syndrome
Cholesteryl ester transfer protein
DalCor Pharmaceuticals Inc
0 catalysts
Phase 3
danicamtiv
Dilated Cardiomyopathy
Cardiac myosin
Bristol-Myers Squibb Co
0 catalysts
Phase 3
daniluromer
daniluromer [INN]
Contact Dermatitis
$EDSAEdesa Biotech, Inc.
0 catalysts
Phase 3
darovasertib
Metastatic Uveal Melanoma
$IDYAIDEAYA Biosciences, Inc.
0 catalysts
Phase 3
dazdotuftide
dazdotuftide [INN]
Anterior Uveitis
Tarsier Pharma Ltd
0 catalysts
Phase 3
dazukibart
Dermatomyositis
Interferon beta
$PFEPFIZER INC
0 catalysts
Phase 3
defactinib hydrochloride
Fallopian Tube Cancer
$VSTMVerastem, Inc.
0 catalysts
Phase 3
delamanid
Deltyba (delamanid)
Pulmonary Tuberculosis
Otsuka Pharmaceutical Co Ltd
0 catalysts